The importance of NLRP3 in mechanisms of CYP-induced cystitis was demonstrated in previous studies showing that inhibition of NLRP3 prevented increase in urinary IL-1β levels and reduced inflammation and bladder dysfunction in CYP-treated rats [47]. Here, NLRP3 is linked to chronic cystitis.